How Heidi is Empowering Clinicians with an AI-Powered Care Partner

Heidi, the fast-growing healthcare AI company empowering clinicians, led by Dr. Tom Kelly, Waleed Mussa, and Yu Liu, has secured a $65 million Series B funding round, led by Point72 Private Investments with participation from continuing investors Blackbird, Headline, and Latitude, the growth fund of Phoenix Court, bringing the total funding to about $100 million and valuing the company at $465 million.

The Series B funding will accelerate Heidi’s mission to build an AI Care Partner that supports clinicians by automating tasks like documentation, evidence search, and follow-ups. With clinicians spending nearly as much time on admin work as on patient care, Heidi has already returned over 18 million hours to frontline workers in just 18 months.

Tens of thousands of clinicians across 200+ specialties rely on Heidi to ease administrative overload. In just 18 months, Heidi has supported 73 million patient consults and now assists with over two million consults weekly in 110 languages across 116 countries.

With the new Series B funding, Heidi plans to expand its team, offices, and local presence in the USA, UK, and Canada, while strengthening clinician-led adoption in France, Spain, Germany, Ireland, South Africa, Singapore, and Hong Kong.

Heidi’s AI is being adopted across major healthcare systems worldwide. In the UK, it’s powering the largest ambient AI deployment with Modality Partnership and Cambridge University Hospitals, and is in pilots with NHS Trusts serving over four million people. In the US, it partners with Beth Israel Lahey Health and MaineGeneral. It’s the official AI provider for the Yukon Government in Canada, supports Australia’s Monash Health and Queensland Health Children’s Hospital, and is one of only two AI providers approved for public trials by New Zealand’s Health Ministry.